Characteristics and outcomes of COVID-19 patients presumed to be treated with sotrovimab in NHS hospitals in England
Abstract Background The impact of the constantly evolving severe acute respiratory syndrome coronavirus 2 on the effectiveness of early coronavirus disease 2019 (COVID-19) treatments is unclear. Here, we report characteristics and acute clinical outcomes of patients with COVID-19 treated with a mono...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2024-04-01
|
| Col·lecció: | BMC Infectious Diseases |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12879-024-09311-2 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|